股本结构
单位：万股
| 公告日期 | 2024-08-14 | 2024-04-25 | 2023-11-13 | 2023-09-12 | 2023-09-12 | 2023-08-11 |
|---|---|---|---|---|---|---|
| 证券总股本 | 658.39 | 658.39 | 537.43 | 537.42 | 537.41 | 537.42 |
| 普通股本 | 658.39 | 658.39 | 537.43 | 537.42 | 537.41 | 537.42 |
| 优先股 | 0.03 | 未披露 | 0.03 | 未披露 | 未披露 | 未披露 |
| 其他 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 |
| 变动日期 | 2024-06-30 | 2024-04-08 | 2023-09-30 | 2023-09-07 | 2023-08-18 | 2023-08-14 |
注释：中概股证券总股本=普通股股本/
存托凭证比例
历史变动
| 公告日期 | 变动后普通股本（万股） | 变动后优先股（万股） | 变动原因 | 变动日期 |
|---|---|---|---|---|
| 2024-08-14 | 658.39 | 0.03 |
更多>>
From March 31, 2024 to June 30, 2024
Issuance of common stock pursuant to private placement
|
2024-06-30 |
| 2024-04-25 | 658.39 | 未披露 | 定期报告 | 2024-04-08 |
| 2023-11-13 | 537.43 | 0.03 |
更多>>
From June 30, 2023 to September 30, 2023
Issuance of common stock pursuant to private placement
Issuance of common stock pursuant to stock plans
|
2023-09-30 |
| 2023-09-12 | 537.42 | 未披露 | 定期报告 | 2023-09-07 |
| 2023-09-12 | 537.41 | 未披露 | 定期报告 | 2023-08-18 |
| 2023-08-11 | 537.42 | 未披露 |
更多>>
Molecular Templates, Inc. announced that the Board and stockholders of the Company approved a 1-for-15 reverse stock split of the Company’s common stock at a special meeting of the Company held on August 11, 2023.
|
2023-08-14 |
| 2023-08-10 | 8061.28 | 未披露 | 定期报告 | 2023-08-07 |
| 2023-08-10 | 8061.27 | 未披露 | 定期报告 | 2023-07-31 |
| 2023-07-18 | 8061.23 | 未披露 | 定期报告 | 2023-07-17 |
| 2022-11-10 | 5635.16 | 0.03 | 定期报告 | 2022-09-30 |
| 2022-08-12 | 5635.16 | 未披露 | 定期报告 | 2022-08-08 |
| 2022-08-11 | 5633.96 | 0.03 | 定期报告 | 2022-06-30 |
| 2022-05-13 | 5633.92 | 未披露 | 定期报告 | 2022-05-09 |
| 2022-03-29 | 5630.50 | 0.03 |
更多>>
From December 31, 2020 to December 31, 2021
Issuance of common stock pursuant to stock plans
Issuance of common stock in at-the-market offering, net of issuance costs of $4.8 million
|
2021-12-31 |
| 2021-11-15 | 5629.80 | 0.03 | 定期报告 | 2021-09-30 |
| 2021-08-13 | 5614.24 | 未披露 | 定期报告 | 2021-08-09 |
| 2021-08-12 | 5613.84 | 0.03 | 定期报告 | 2021-06-30 |
| 2021-05-14 | 5609.45 | 未披露 | 定期报告 | 2021-05-10 |
| 2021-04-27 | 5608.76 | 未披露 | 定期报告 | 2021-04-07 |
| 2021-05-14 | 5608.29 | 0.03 |
更多>>
From December 31, 2020 To March 31, 2021
Issuance of common stock pursuant to public offering
|
2021-03-31 |
| 2021-03-19 | 5605.23 | 未披露 | 定期报告 | 2021-03-17 |
| 2021-02-22 | 5596.37 | 未披露 |
更多>>
1.Common stock offered by the company 6,000,000 shares.
2.The number of shares of common stock expected to be outstanding after this offering and, unless otherwise indicated, the information in this prospectus supplement are based on 49,963,732 shares of common stock outstanding as of September 30, 2020.
|
2021-02-22 |
| 2021-03-19 | 4998.43 | 0.03 |
更多>>
from December 31, 2019 to December 31, 2020
Issuance of common stock pursuant to stock plans
Issuance of common stock in at-the-market offering, net of issuance costs of $1.6 million
|
2020-12-31 |
| 2020-11-06 | 4996.42 | 未披露 | 定期报告 | 2020-11-02 |
| 2020-11-05 | 4996.37 | 0.03 | 定期报告 | 2020-09-30 |
| 2020-08-07 | 4991.93 | 未披露 | 定期报告 | 2020-08-04 |
| 2020-08-06 | 4577.89 | 0.03 | 定期报告 | 2020-06-30 |
| 2020-06-04 | 4573.03 | 未披露 | 定期报告 | 2020-05-29 |
| 2020-05-12 | 4570.78 | 未披露 | 定期报告 | 2020-05-08 |
| 2020-04-23 | 4570.56 | 未披露 | 定期报告 | 2020-04-08 |
| 2020-05-12 | 4570.39 | 0.03 | 定期报告 | 2020-03-31 |
| 2020-03-13 | 4564.79 | 未披露 | 定期报告 | 2020-03-12 |
| 2020-03-13 | 4558.92 | 0.03 |
更多>>
From December 31, 2018 to December 31, 2019
Issuance of common stock in a public offering, net of issuance costs of $3.8 million
Issuance of common stock pursuant to stock plans
Issuance of common stock through Private Placement,net of issuance costs of $75 thousand
|
2019-12-31 |
| 2019-11-25 | 4295.45 | 未披露 | 定期报告 | 2019-11-25 |
| 2019-11-12 | 3696.85 | 未披露 | 定期报告 | 2019-11-04 |
| 2019-11-12 | 3695.45 | 未披露 | 定期报告 | 2019-09-30 |
| 2019-08-12 | 3693.66 | 未披露 | 定期报告 | 2019-08-05 |
| 2019-08-12 | 3688.22 | 未披露 |
更多>>
From March 31, 2019 to June 30, 2019
Issuance of common stock pursuant to stock plans
|
2019-06-30 |
| 2019-05-13 | 3676.92 | 未披露 | 定期报告 | 2019-05-03 |
| 2019-04-26 | 3676.17 | 未披露 | 定期报告 | 2019-04-08 |
| 2019-05-13 | 3675.67 | 未披露 | 定期报告 | 2019-03-31 |
| 2019-03-29 | 3673.60 | 未披露 |
更多>>
from December 31, 2017 to December 19, 2018
Issuance of common stock pursuant to stock plans
Issuance of common stock in a public offering, net of issuance costs of $3.8 million
|
2018-12-19 |
| 2018-11-13 | 3649.61 | 未披露 | 定期报告 | 2018-09-30 |
| 2018-09-24 | 3649.52 | 未披露 | 定期报告 | 2018-09-20 |
| 2018-08-09 | 2706.52 | 未披露 | 定期报告 | 2018-06-30 |
| 2018-05-14 | 2706.06 | 未披露 | 定期报告 | 2018-05-10 |
| 2018-05-14 | 2706.00 | 未披露 | 定期报告 | 2018-03-31 |
| 2018-03-30 | 2705.82 | 未披露 | 定期报告 | 2018-03-21 |
| 2018-03-30 | 2689.83 | 未披露 |
更多>>
from December 31, 2016 to December 31, 2017
Conversion of preferred stock to common stock in connection with merger
Issuance of common stock pursuant to stock plans
Conversion of preferred stock warrants to common stock in connection with merger
Conversion of redeemable convertible notes to common stock
Issuance of common stock and assumption of options in connection with the merger
Issuance of common stock to Takeda and certain other investors, net of issuance costs of $2.4 million
|
2017-12-31 |
| 2017-11-14 | 2689.52 | 未披露 | 定期报告 | 2017-11-08 |
| 2017-11-14 | 2688.42 | 未披露 | 定期报告 | 2017-09-30 |
| 2017-09-15 | 2688.09 | 未披露 |
更多>>
On August 1, 2017, we completed our business combination with Molecular Templates OpCo in accordance with the terms of the Merger Agreement. Pursuant to the Merger Agreement, we formed a wholly owned subsidiary that merged with and into Molecular Templates OpCo, with Molecular Templates OpCo surviving the Merger and becoming our wholly owned subsidiary.
|
2017-08-15 |
| 2015-11-02 | 7143.11 | 未披露 | 定期报告 | 2015-09-30 |
| 2015-07-30 | 7133.48 | 未披露 | 定期报告 | 2015-06-30 |
| 2015-04-30 | 7133.44 | 未披露 | 定期报告 | 2015-03-31 |
| 2015-03-03 | 6289.82 | 未披露 |
更多>>
from December 31, 2013 to December 31, 2014
Exercise of warrants to purchase common stock
Issuance of common stock pursuant to stock plans
|
2014-12-31 |
| 2014-11-03 | 6243.69 | 未披露 | 定期报告 | 2014-09-30 |
| 2014-08-01 | 5936.52 | 未披露 | 定期报告 | 2014-06-30 |
| 2014-04-07 | 5934.60 | 未披露 | 定期报告 | 2014-03-31 |
| 2014-03-06 | 5923.26 | 未披露 |
更多>>
from December 31, 2012 to December 31, 2013
Exercise of warrants to purchase common stock
Issuance of common stock pursuant to stock plans
|
2013-12-31 |
| 2013-11-04 | 5922.41 | 未披露 | 定期报告 | 2013-10-25 |
| 2013-11-04 | 5917.41 | 未披露 | 定期报告 | 2013-09-30 |
| 2013-08-01 | 5808.32 | 未披露 | 定期报告 | 2013-07-26 |
| 2013-08-01 | 5799.21 | 未披露 | 定期报告 | 2013-06-30 |
| 2013-05-02 | 5654.81 | 未披露 | 定期报告 | 2013-04-26 |
| 2013-04-03 | 5654.66 | 未披露 | 定期报告 | 2013-03-22 |
| 2013-03-07 | 5653.58 | 未披露 | 定期报告 | 2013-02-28 |
| 2013-03-07 | 5643.12 | 未披露 |
更多>>
from December 31, 2011 to December 31, 2012
Issuance of common stock to certain investors, net of issuance costs of $0.4 million
Exercise of warrants to purchase common stock
Issuance of common stock pursuant to stock plans
|
2012-12-31 |
| 2012-11-02 | 5625.14 | 未披露 | 定期报告 | 2012-10-31 |
| 2012-11-02 | 5621.61 | 未披露 | 定期报告 | 2012-09-30 |
| 2012-08-06 | 5512.37 | 未披露 | 定期报告 | 2012-07-31 |
| 2012-08-06 | 5512.26 | 未披露 | 定期报告 | 2012-06-30 |
| 2012-05-03 | 5449.98 | 未披露 | 定期报告 | 2012-04-30 |
| 2012-05-03 | 5410.17 | 未披露 | 定期报告 | 2012-03-31 |
| 2012-03-15 | 5153.23 | 未披露 | 定期报告 | 2012-02-29 |
| 2011-11-03 | 4912.85 | 未披露 | 定期报告 | 2011-09-30 |
| 2011-08-04 | 4906.16 | 未披露 | 定期报告 | 2011-07-31 |
| 2011-05-12 | 4880.50 | 未披露 | 定期报告 | 2011-04-30 |
| 2011-05-12 | 4880.32 | 未披露 | 定期报告 | 2011-03-31 |
| 2011-03-24 | 4879.61 | 未披露 | 定期报告 | 2011-03-16 |
| 2010-11-04 | 3370.22 | 未披露 | 定期报告 | 2010-09-30 |
| 2010-05-06 | 3363.82 | 未披露 | 定期报告 | 2010-03-31 |
| 2010-03-08 | 3356.37 | 未披露 |
更多>>
from December 31, 2008 to December 31, 2009
Issuance of common stock to certain investors, net of issuance costs of $1.9 million
Issuance of common stock pursuant to stock plans
|
2009-12-31 |
| 2009-03-13 | 1521.40 | 未披露 |
更多>>
from December 31, 2007 to December 31, 2008
Issuance of common stock and warrants to certain investors, net of issuance costs of $1.5 million
Issuance of common stock pursuant to stock plans
Repurchase of unvested common stock
On August 13, 2008, the Company’s Board of Directors approved a 1-for-6 reverse split of its common stock, following approval by the Company’s stockholders on May 13, 2008. The reverse stock split was effective August 20, 2008.
|
2008-12-31 |
| 2008-03-12 | 3736.83 | 未披露 |
更多>>
from December 31, 2006 to December 31, 2007
Issuance of common stock pursuant to stock plans
Repurchase of unvested common stock
|
2007-12-31 |
| 2007-03-15 | 3734.59 | 未披露 |
更多>>
from December 31, 2005 to December 31, 2006
Issuance of common stock pursuant to stock plans
Repurchase of unvested common stock
|
2006-12-31 |
| 2006-03-28 | 3723.16 | 未披露 |
更多>>
from December 31, 2004 to December 31, 2005
Issuance of common stock in an initial public offering for cash of $7.00, per share, net of issuance costs of $4.6 million
Issuance of common stock for cash of $10.46 per share, net of issuance costs of $4.5 million
Issuance of common stock pursuant to exercise of warrants
Conversion of convertible preferred stock upon initial public offering
Issuance of common stock pursuant to stock plans
Repurchase of unvested common stock
|
2005-12-31 |
From March 31, 2024 to June 30, 2024
Issuance of common stock pursuant to private placement
From June 30, 2023 to September 30, 2023
Issuance of common stock pursuant to private placement
Issuance of common stock pursuant to stock plans
Molecular Templates, Inc. announced that the Board and stockholders of the Company approved a 1-for-15 reverse stock split of the Company’s common stock at a special meeting of the Company held on August 11, 2023.
From December 31, 2020 to December 31, 2021
Issuance of common stock pursuant to stock plans
Issuance of common stock in at-the-market offering, net of issuance costs of $4.8 million
From December 31, 2020 To March 31, 2021
Issuance of common stock pursuant to public offering
1.Common stock offered by the company 6,000,000 shares.
2.The number of shares of common stock expected to be outstanding after this offering and, unless otherwise indicated, the information in this prospectus supplement are based on 49,963,732 shares of common stock outstanding as of September 30, 2020.
from December 31, 2019 to December 31, 2020
Issuance of common stock pursuant to stock plans
Issuance of common stock in at-the-market offering, net of issuance costs of $1.6 million
From December 31, 2018 to December 31, 2019
Issuance of common stock in a public offering, net of issuance costs of $3.8 million
Issuance of common stock pursuant to stock plans
Issuance of common stock through Private Placement,net of issuance costs of $75 thousand
From March 31, 2019 to June 30, 2019
Issuance of common stock pursuant to stock plans
from December 31, 2017 to December 19, 2018
Issuance of common stock pursuant to stock plans
Issuance of common stock in a public offering, net of issuance costs of $3.8 million
from December 31, 2016 to December 31, 2017
Conversion of preferred stock to common stock in connection with merger
Issuance of common stock pursuant to stock plans
Conversion of preferred stock warrants to common stock in connection with merger
Conversion of redeemable convertible notes to common stock
Issuance of common stock and assumption of options in connection with the merger
Issuance of common stock to Takeda and certain other investors, net of issuance costs of $2.4 million
On August 1, 2017, we completed our business combination with Molecular Templates OpCo in accordance with the terms of the Merger Agreement. Pursuant to the Merger Agreement, we formed a wholly owned subsidiary that merged with and into Molecular Templates OpCo, with Molecular Templates OpCo surviving the Merger and becoming our wholly owned subsidiary.
from December 31, 2013 to December 31, 2014
Exercise of warrants to purchase common stock
Issuance of common stock pursuant to stock plans
from December 31, 2012 to December 31, 2013
Exercise of warrants to purchase common stock
Issuance of common stock pursuant to stock plans
from December 31, 2011 to December 31, 2012
Issuance of common stock to certain investors, net of issuance costs of $0.4 million
Exercise of warrants to purchase common stock
Issuance of common stock pursuant to stock plans
from December 31, 2008 to December 31, 2009
Issuance of common stock to certain investors, net of issuance costs of $1.9 million
Issuance of common stock pursuant to stock plans
from December 31, 2007 to December 31, 2008
Issuance of common stock and warrants to certain investors, net of issuance costs of $1.5 million
Issuance of common stock pursuant to stock plans
Repurchase of unvested common stock
On August 13, 2008, the Company’s Board of Directors approved a 1-for-6 reverse split of its common stock, following approval by the Company’s stockholders on May 13, 2008. The reverse stock split was effective August 20, 2008.
from December 31, 2006 to December 31, 2007
Issuance of common stock pursuant to stock plans
Repurchase of unvested common stock
from December 31, 2005 to December 31, 2006
Issuance of common stock pursuant to stock plans
Repurchase of unvested common stock
from December 31, 2004 to December 31, 2005
Issuance of common stock in an initial public offering for cash of $7.00, per share, net of issuance costs of $4.6 million
Issuance of common stock for cash of $10.46 per share, net of issuance costs of $4.5 million
Issuance of common stock pursuant to exercise of warrants
Conversion of convertible preferred stock upon initial public offering
Issuance of common stock pursuant to stock plans
Repurchase of unvested common stock